ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Core Grants Limit Formula Must Wait On Profiles

January 27, 1978

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

Pursuit Of Truth Was Not An NIH Objective In Gallo Case, Dingell Staff Report Says

January 6, 1995

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974